STHS Staff Wear Orange to Raise Awareness of Gun Violence

Translate to Spanish or other 102 languages!

Standing in Solidarity Against Gun Violence: Deemed a public health problem, gun-related mortality and injury rates remain high across the country. Image courtesy of STHS
Standing in Solidarity Against Gun Violence: Deemed a public health problem, gun-related mortality and injury rates remain high across the country. Image courtesy of STHS
- Advertisement -

National Gun Violence Awareness Day is a day to raise awareness and honor the survivors of gun violence, South Texas Health System staff across its 12 facilities wore orange to stand in solidarity with those working to end gun violence. 

Standing in Solidarity Against Gun Violence: Deemed a public health problem, gun-related mortality and injury rates remain high across the country. 

Firearm injuries are among the five leading causes of death for people between the ages of 1 and 44 years old, per the CDC, with more than 48,000 firearm-related deaths reported. That’s about 132 people who lose their lives each day due to firearm-related injuries.  

- Advertisement -

See the galley below for more images courtesy of STHS:

So, this National Gun Violence Awareness Day, also referred to as National Wear Orange Day, South Texas Health System employees, including members of STHS McAllen’s Level 1 Trauma Center, donned orange attire to stand in solidarity against gun violence, honor the victims of gun violence and promote the importance of gun safety.

While gun violence has become more prevalent over the past few decades, it’s important to know that gun violence is preventable through mental health support and community-based violence prevention programs, as well as by addressing the root causes of violence.

Together, we can build a future free from gun violence.

- Advertisement -

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.
- Advertisement -